Tuesday, November 18, 2014
Print Current Session:
|
|
Tuesday
SESSION 12:
IN HONOR OF ROBERT B. RUTHERFORD, MD: NEW DEVELOPMENTS IN THE TREATMENT OF LOWER EXTREMITY ISCHEMIA; CLI, STENTS AND DEBs
Moderators:Ali F. AbuRahma, MD / Dierk Scheinert, MD
|
|
SESSION 12 SCHEDULE | |
FOR SFA AND POPLITEAL LESIONS | |
9:48 AM - 9:53 AM | Update On The Efficacy Of DEBs For SFA And Popliteal Artery Lesions: Why Some Trials Are Positive And Some Negative: Are Good Results Holding Up: GLOBAL IN.PACT Registry Results In >1400 Patients |
Presenter(s):Gunnar Tepe, MD / Dierk Scheinert, MD | |
View Abstract | |
9:54 AM - 9:59 AM | POBA And “Vanella” Bare Metal Stents (BMS) Have Merit In Some AK And BK Occlusive Lesions Reserving The Fancy And Costly Stuff For Special Situations |
Presenter(s):Iris Baumgartner, MD | |
View Abstract | |
10:00 AM - 10:05 AM | What Have We In The US Learned From Our European Colleagues About CLI Treatment That Can Be Used To Improve Patient Care In The US |
Presenter(s):Craig M. Walker, MD | |
View Abstract | |
10:06 AM - 10:11 AM | Stenting For Femoral And Popliteal Artery Lesions: Where Do We Currently Stand And What Problems Remain |
Presenter(s):Erich Minar, MD | |
View Abstract | |
10:12 AM - 10:17 AM | Role Of DEBs vs. DESs For SFA Lesions And Value Of Paclitaxel DEBs For Long SFA Lesions: Is There Level 1 Proof Of Benefit |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
10:18 AM - 10:23 AM | Paclitaxel Coated DEBs Are Better Than Uncoated Balloons In The SFA: 1-Year Results From The IN.PACT SFA I/II RCTs |
Presenter(s):Peter A. Schneider, MD / John R. Laird, MD / Gunnar Tepe, MD | |
View Abstract | |
10:24 AM - 10:29 AM | DEBs Are Effective For SFA Lesions: 1-Year Results From The LEVANT II RCT Show It To Be So With The Bard Lutonix DEB: Stents Were Rarely Needed |
Presenter(s):Kenneth Rosenfield, MD / Dierk Scheinert, MD | |
View Abstract | |
10:30 AM - 10:35 AM | Durability Of Paclitaxel Coated DEBs In The SFA: Long-Term (3-Year) Results Of The PACIFIER Trial |
Presenter(s):Michael Werk, MD | |
View Abstract | |
10:36 AM - 10:41 AM | Mid-Term Results From The Belgian IN.PACT Trial Of Paclitaxel Coated DEBs vs. POBA: What Is Special About This Trial |
Presenter(s):Erik E. Debing, MD, PhD | |
View Abstract | |
10:42 AM - 10:50 AM | Panel Discussion |
FOR BK AND INFRAPOPLITEAL LESIONS | |
Moderator(s): Michael S. Conte, MD / George H. Meier III, MD | |
10:50 AM - 10:55 AM | How Often After Tibial Interventions For CLI Are Reinterventions Required: We Need Better Primary Treatments: What Are The Cost Implications |
Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD | |
View Abstract | |
10:56 AM - 11:01 AM | Single Center RCT Of IN.PACT Deep Paclitaxel Coated DEBs vs. Uncoated Balloons Shows Benefit For BK Lesions Causing CLI: 3-Year Results Of The DEBATE Trial |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:02 AM - 11:07 AM | Single Center Results With Paclitaxel Coated DEBs For Infrapopliteal Lesions Shows Benefits: What Are They |
Presenter(s):Andrej Schmidt, MD / Dierk Scheinert, MD | |
View Abstract | |
11:08 AM - 11:13 AM | A Multicenter RCT (IN.PACT DEEP) Comparing Paclitaxel Coated DEBs With Uncoated Balloons Fails To Show Benefit For The DEBs |
Presenter(s):Thomas Zeller, MD | |
View Abstract | |
11:14 AM - 11:19 AM | Why Do The SINGLE CENTER Trial And Other BK DEB Results Differ From The Multicenter Trial Results: All DEBs Are Not Equal Or Used Equally: A Critical Analysis Of All Data And Some 3-Year Results |
Presenter(s):Francesco Liistro, MD | |
View Abstract | |
11:20 AM - 11:25 AM | How To Explain Differing Results Of RCTs Of DEBs In BK And Infrapopliteal Lesions: When Will We Get DEBs For BK Lesions In The US |
Presenter(s):Krishna J. Rocha-Singh, MD | |
View Abstract | |
11:26 AM - 11:31 AM | DEBs: Are They A Breakthrough Technology Or Another Tool In The Box: Why Is There Still Uncertainty: Do The PACUBA Trial Results With SFA/POP In Stent Restenosis (ISR) Help |
Presenter(s):Johannes Lammer, MD | |
View Abstract | |
11:32 AM - 11:37 AM | How Long Is Restored Patency Needed In CLI Patients; What Leads To Increased Limb Salvage With Poor Patency: Importance Of Reintervention, DESs And DEBs |
Presenter(s):Frank E.G. Vermassen, MD, PhD | |
View Abstract | |
11:38 AM - 11:43 AM | How Important To Interventional Outcomes Is Leaving No Foreign Body Or Metal Behind In The Artery: How Can It Be Achieved |
Presenter(s):Giancarlo Biamino, MD, PhD / Dierk Scheinert, MD | |
View Abstract | |
11:44 AM - 11:49 AM | Variable And High Total Costs For Caring For CLI Patients: What Can Be Done To Cut Costs Without Impairing Patient Care |
Presenter(s):Timothy M. Sullivan, MD | |
View Abstract | |
11:50 AM - 12:00 PM | Panel Discussion |
12:00 PM - 1:00 PM | Lunch Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
END OF SESSION 12 | |
previous | next |